CAW
ECYT

Cornerstone Advisors (Washington)’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-250
Closed -$1K – 941
2016
Q2 		$1K Hold
250
– – ﹤0.01% 851
2016
Q1 		$1K Hold
250
– – ﹤0.01% 847
2015
Q4 		$1K Hold
250
– – ﹤0.01% 885
2015
Q3 		$1K Buy
+250
New +$1.31K ﹤0.01% 868

Other funds holding ECYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cornerstone Advisors (Washington)'s ECYT Position: Q3 2016 in Review

Cornerstone Advisors (Washington) sold out of Endocyte, Inc. Common Stock (ECYT) in Q3 2016, closing a stake of 250 shares — an estimated $1K sold.

Cornerstone Advisors (Washington) first reported a position in ECYT in Q3 2015 and held it in 4 quarters. The position peaked at $1K in Q2 2016. 90 funds tracked by Wall St. Rank hold ECYT as of Q3 2016.

  • Cornerstone Advisors (Washington) reported no remaining Endocyte, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • Cornerstone Advisors (Washington) sold 250 Endocyte, Inc. Common Stock shares in Q3 2016, an estimated $1K.
  • Cornerstone Advisors (Washington) first reported a position in Endocyte, Inc. Common Stock in Q3 2015 and held it in 4 quarters.
  • Cornerstone Advisors (Washington)'s Endocyte, Inc. Common Stock position peaked at $1K in Q2 2016.
  • 90 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q3 2016.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2016, filed 21 Oct 2016.